Articles tagged with Pharmaceuticals
New Zealand Implements 'Rule of Two' for Faster Medicine Approvals
1 week ago | 92 viewsAssociate Health Minister David Seymour welcomes the passing of the Medicines Amendment Bill, which introduces the 'Rule of Two' for faster approval of medicines with recognition from two overseas jurisdictions. The streamlined verification pathway aims to increase access to medicines for New Zealanders, starting with countries like Australia, the United States, and the United Kingdom. The government prioritizes improving patient outcomes by enhancing access to medicines through initiatives like increased Pharmac funding, patient input in funding decisions, and efficient regulatory processes.
Tags: David Seymour Medicines Amendment Bill Rule of Two Kiwis New Zealand Medsafe Pharmac pharmaceuticals patient outcomes regulatory approvalPharmac's Reset Programme Progress: 90-Day Action Plan Completion and Consumer Engagement
3 weeks ago | 153 viewsPharmac's Reset Programme, part of a five-year plan, is progressing well with the completion of the first 90-day action plan, focusing on transparency and accountability in funding decisions for pharmaceuticals. Associate Health Minister David Seymour emphasizes the importance of involving patients, families, and clinicians in decision-making processes to improve the patient-Pharmac relationship. The Consumer and Patient Working Group, chaired by Dr. Malcolm Mulholland, plays a key role in providing insight and practical advice to ensure the programme reflects consumer needs, values, and perspectives, with ongoing plans to enhance patient engagement and communication strategies.
Tags: Pharmac’s Reset Programme Associate Health Minister David Seymour New Zealanders pharmaceuticals Consumer Engagement Workshops Dr Malcolm Mulholland Consumer and Patient Working Group Budget bids Consumer Advisory CommitteeNew Zealand's Bioeconomy Boost: Government Invests $42M in Biodiscovery Platform for High-Value Exports
1 month ago | 233 viewsThe New Zealand government is investing over $42 million in a Biodiscovery Platform to develop high-value pharmaceutical and bio-based exports from the country's natural resources. Led by the Bioeconomy Science Institute, this initiative aims to tap into the global market for bio-based products, particularly natural pharmaceuticals, which is expected to exceed $300 billion by 2027. By supporting research, innovation, and commercialization, the platform seeks to create jobs, grow businesses, and strengthen New Zealand's economy in alignment with the country's strategic focus on science and technology.
Tags: Shane Reti New Zealand Biodiscovery Platform Bioeconomy Science Institute pharmaceuticals innovation economy biodiversity export opportunitiesNew Zealand's Medsafe Achieves Record Approval Speeds for Life-Saving Medicines
3 months ago | 573 viewsAssociate Health Minister David Seymour highlights that Medsafe has been improving its efficiency in approving new medicines, with significant reductions in evaluation timeframes for both innovative and generic medicines. The implementation of initiatives like the Rule of Two and leveraging AI technology are expected to further expedite the approval processes. The focus is on ensuring faster access to vital medications for New Zealanders, with a commitment to a regulatory system that prioritizes timely approval without compromising safety.
Tags: Medsafe David Seymour New Zealanders pharmaceuticals Rule of Two AI Medicines Amendment Bill Bleriplex medicine Omjjaro Tyruko